Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,962 | -9,054 | -5,345 | 6,899 | 6,359 |
| Depreciation Amortization | 913 | 328 | 1,269 | 948 | 630 |
| Accounts receivable | -6,673 | -15,704 | -14,142 | -33,240 | -39,400 |
| Other Working Capital | -20,773 | -24,542 | 16,472 | -5,399 | -24,626 |
| Other Operating Activity | 26,813 | 27,765 | 69,738 | 67,655 | 65,795 |
| Operating Cash Flow | $-17,682 | $-21,207 | $67,992 | $36,863 | $8,758 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,141 | -62 | -119 | -49 | 28 |
| Other Investing Activity | -3,000 | 0 | -7,807 | 0 | 0 |
| Investing Cash Flow | $-4,141 | $-62 | $-7,926 | $-49 | $28 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,000 | 10,000 | 10,000 |
| Debt Repayment | N/A | N/A | -462 | -462 | -462 |
| Common Stock Issued | 3,476 | 151 | 68,363 | 68,300 | 67,187 |
| Other Financing Activity | -10,940 | -1,077 | -4,974 | -63 | -63 |
| Financing Cash Flow | $-7,464 | $-926 | $72,927 | $77,775 | $76,662 |
| Beginning Cash Position | 186,543 | 186,543 | 53,550 | 53,550 | 53,550 |
| End Cash Position | 157,256 | 164,348 | 186,543 | 168,139 | 138,998 |
| Net Cash Flow | $-29,287 | $-22,195 | $132,993 | $114,589 | $85,448 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,682 | -21,207 | 67,992 | 36,863 | 8,758 |
| Capital Expenditure | -1,141 | -62 | -291 | -221 | -144 |
| Free Cash Flow | -18,823 | -21,269 | 67,701 | 36,642 | 8,614 |